GODAVARIBGodavari Biorefineries Limited
Convert to ideaMetals & Mining · Commodity Chemicals
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeDown 0.6 this quarter.
Momentum from moving averages, Supertrend and RSI.
3 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
3 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹549 Cr | ₹-15 Cr | -0.89% | -2.77% | ₹-2.98 | -0.3x |
| Q1 FY2027 | ₹558 Cr | ₹-19 Cr | -2.50% | -3.46% | ₹-3.78 | -0.9x |
| Q4 FY2026 | ₹564 Cr | ₹53 Cr | 12.82% | 9.37% | ₹10.33 | 7.2x |
| Q3 FY2026 | ₹460 Cr | ₹8 Cr | 6.42% | 1.79% | ₹1.61 | 2.3x |
| Q2 FY2026 | ₹431 Cr | ₹-42 Cr | -4.98% | -9.66% | ₹-8.13 | -3.6x |
| Q1 FY2026 | ₹533 Cr | ₹-16 Cr | -1.45% | -3.00% | ₹-3.13 | -0.5x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Commodity Chemicals
Compare with peers →Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.